CLEC4G Promotes Pancreatic Cancer Progression by Suppressing Cathepsin B‐Mediated Ferroptosis: Evidence From Mendelian Randomization Study and Experimental Validation
Human Mutation · 2026-01 · 2026 (1)
DOI: 10.1155/humu/7359548 ↗Kurz gefasst
Fachartikel in der Zeitschrift Human Mutation, online erschienen am 10.06.2026. Verfasst von Zhichen Jiang und 11 weiteren Autor:innen. Beteiligte Einrichtung: General Surgery, Cancer Center, Department of Gastrointestinal and Pancreatic Surgery, Zhejiang Provincial People's Hospital (Affiliated People's Hos…. Hauptthemen laut MEDLINE: Ferroptosis, Pancreatic Neoplasms, Cathepsin B, Lectins, C-Type. Die Arbeit nennt 44 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Pancreatic cancer (PC) is highly lethal and lacks causal biomarkers that can inform mechanism‐based therapies. Ferroptosis is an iron‐dependent form of regulated cell death implicated in PC, but upstream determinants of ferroptosis in PC remain unclear. We integrated large‐scale proteomic quantitative trait locus (pQTL) resources with Mendelian randomization (MR) and cell‐based experiments to identify causal regulators of ferroptosis relevant to PC. Using two‐sample MR with plasma pQTL data from the deCODE cohort and the UK Biobank Pharma Proteomics Project and PC genome‐wide association summary statistics from FinnGen, we screened 159 FerrDb‐defined ferroptosis‐related proteins and identified three ferroptosis‐related proteins (CTSB, IDO1, and MDM4) with significant causal effects on PC risk. A proteome‐wide scan further uncovered 13 proteins associated with PC. Two‐step mediation MR supported a causal pathway from CLEC4G through the ferroptosis regulator CTSB to PC risk. In vitro, CLEC4G knockdown increased CTSB expression and ferroptosis activity, which suppressed PC cell proliferation, colony formation, migration, and invasion. Together, our genetic and experimental evidence indicates that CLEC4G promotes PC progression by limiting CTSB‐associated ferroptotic activity in PC cells and supports further investigation of the CLEC4G–CTSB axis in PC.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- General Surgery, Cancer Center, Department of Gastrointestinal and Pancreatic Surgery, Zhejiang Provincial People's Hospital (Affiliated People's Hospital), Hangzhou Medical College, Hangzhou, Zhejiang, China, hznu.edu.…
- Key Laboratory of Gastroenterology of Zhejiang Province, Hangzhou, Zhejiang, China.
- State Key Laboratory of Molecular Oncology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China, cacm…
ORCID-Profile: Zhichen Jiang, Yuanyu Wang, Yiping Mou, Weiwei Jin
Zitieren
APA
Jiang, Z., Ma, P., Zhang, S., Jin, Z., Wang, Y., Zhou, Y., Zhu, Q., Lu, C., Tu, N., Zhang, Z. A., Mou, Y., & Jin, W. (2026). CLEC4G Promotes Pancreatic Cancer Progression by Suppressing Cathepsin B‐Mediated Ferroptosis: Evidence From Mendelian Randomization Study and Experimental Validation. Human Mutation, 2026(1). https://doi.org/10.1155/humu/7359548
Vancouver
Jiang Z, Ma P, Zhang S, Jin Z, Wang Y, Zhou Y, et al. CLEC4G Promotes Pancreatic Cancer Progression by Suppressing Cathepsin B‐Mediated Ferroptosis: Evidence From Mendelian Randomization Study and Experimental Validation. Human Mutation. 2026;2026(1). doi:10.1155/humu/7359548
BibTeX
@article{Jiang2026,
author = {Jiang, Zhichen and Ma, Pengcheng and Zhang, Shaobo and Jin, Ze and Wang, Yuanyu and Zhou, Yucheng and Zhu, Qicong and Lu, Chao and Tu, Ninghui and Zhang, Zhi Ang and Mou, Yiping and Jin, Weiwei},
title = {CLEC4G Promotes Pancreatic Cancer Progression by Suppressing Cathepsin B‐Mediated Ferroptosis: Evidence From Mendelian Randomization Study and Experimental Validation},
journal = {Human Mutation},
year = {2026},
volume = {2026},
number = {1},
doi = {10.1155/humu/7359548}
}
EUVIMED